Actively Recruiting
TreAtments and outComes in paTients With prImary CutAneous Lymphoma
Led by Peking University First Hospital · Updated on 2023-11-18
3000
Participants Needed
5
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In order to further improve the diagnosis and treatment level of primary cutaneous lymphoma in China, the National Clinical Center for Skin and Immune Diseases established a standardized diagnosis and treatment center for primary cutaneous lymphoma to systematically and effectively understand the current treatment status of patients with primary cutaneous lymphoma, as well as the efficacy and safety of various treatment methods during practices, so as to further improve the diagnosis and treatment level of primary cutaneous lymphoma and help patients with primary cutaneous lymphoma.
CONDITIONS
Official Title
TreAtments and outComes in paTients With prImary CutAneous Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients from the participating medical centers that have passed the data review of the National Clinical Center for Skin and Immune Diseases
- Patients with a definitive pathological diagnosis of primary cutaneous lymphoma by skin biopsy
You will not qualify if you...
- Patients who fail to provide informed consent form
- Patients who cannot complete the questionnaire independently or under the guidance of investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
2
SUN YAI-SEN Memorial Hospital, SUN YAI-SEN University
Guandong, Guangdong, China, 510235
Actively Recruiting
3
Hospital for Skin Disease, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College
Nanjing, Jiangsu, China, 210042
Actively Recruiting
4
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012
Actively Recruiting
5
Peking University First Hospital
Beijing, China
Actively Recruiting
Research Team
Y
Yang Wang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here